A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Institution/Individual | Region | Contact | Type of Org | Funder Type (if applicable) | Date of last contact | Core Team Member | Comments | ||||||||||||||||||
2 | Beijing Genomics Institute | Beijing | Henry Yang | industry (pharma/tech) | in-kind | Oct-17 | Eddy, Peter | Verbally and via email have committed to sequencing 30% of the discovered virome at own cost. | ||||||||||||||||||
3 | Bill & Melinda Gates Foundation | Seattle | Chris Elias | foundation | direct | Mar-17 | Jonna | Dennis previously meet with Chris Karp and Scott Dowell - seemingly not folks with funding decision-making power. Jonna leading a workshop/panel with Bill Gates in April at NEJM in Boston | ||||||||||||||||||
4 | BioHub | SF/Bay Area | Cristina Tato | industry (pharma/tech) | direct and in-kind | Sep-17 | Jonna | Very interested, moving forward with MOUs | ||||||||||||||||||
5 | Bloomberg Philanthropies | NYC area | missing info | foundation | direct | missing info | Dennis | missing info | ||||||||||||||||||
6 | Boston University | Boston/NE | Jerry Keursch | academia | NA | NA | Dennis | missing info | ||||||||||||||||||
7 | Bush/Scowcroft | Dallas | Andrew Natsios | NGO | direct | Oct-17 | Dennis | Dennis spoke at an event recently. Interested, but have not had in-depth funding conversations | ||||||||||||||||||
8 | Canada - IDRC | Canada | Dominique Charron | government | direct | Oct-17 | Dennis, Eddy, Billy Karesh | Good interactions at Ontario meeting, want to continue to be involved | ||||||||||||||||||
9 | CDC-Atlanta | Washington DC | Stuart Nichol, John Towner | government | in-kind | Jan-17 | Jonna | offered free help around negotiating in country | ||||||||||||||||||
10 | CEPI | London | Richard Hatchett | NGO | NA | Oct-17 | Dennis/Peter | Supportive partner but non-funder. Necessary voice to get buy-in from Gates etc. | ||||||||||||||||||
11 | Chan-Zuckerberg | SF/Bay Area | Cori Bargmann | foundation | direct and in-kind | NA | Nathan/Dennis | Either connection through Nathan or Cristina at BioHub | ||||||||||||||||||
12 | Chatham House | London | David Heymann/David Harper | NGO | NA | Jul-17 | Dennis | Dennis gave talk in July - likely not funders but David Heymann is influential and good to have on our side. | ||||||||||||||||||
13 | China Academy of Science/C-CDC* | Beijing | George Gao | government | direct and in-kind | Oct-17 | Peter | Most recent engagement via Eddy at Beijing Genome Conference. Eager, interested, need firm financial commitment. | ||||||||||||||||||
14 | China CAS | Beijing | George Gao | government | in-kind | Oct-17 | Peter | Most recent engagement via Eddy at Beijing Genome Conference. Eager, interested, need firm financial commitment. | ||||||||||||||||||
15 | Columbia University | NYC area | Ian Lipkin, Simon Anthony | academia | in-kind | Oct-17 | Peter | Ian Lipkin is chair of the Lab Platform working group. Have discussed costs of sequencing, but has not offered to provide any discounted or in-kind sequencing. | ||||||||||||||||||
16 | Costa Rica/Academy of Science | Costa Rica | Roman Macaya Hayes, Pedro Leon | government | in-kind | Oct-18 | Dennis/Cara | In frequent conversation, likely not bringing any funds. | ||||||||||||||||||
17 | CSIS | Washington DC | Steve Morris | NGO | NA | missing info | missing info | Center for Strategic and International Studies. | ||||||||||||||||||
18 | Dan Janzen UPenn | Costa Rica | NA | academia | in-kind | Nov-17 | Nathan, Jonna | frequent email interactions, most recent in-person meeting on 10/04/17. | ||||||||||||||||||
19 | DARPA | Washington DC | Matt Hepburn | government | direct | Nov-17 | Dennis | Dennis in conversation with Matt Hepburn and setting up additional meetings | ||||||||||||||||||
20 | David Nabarro | NYC area | David Nabarro | influencer | NA | NA | Dennis | Gian Luca Burci (ELSI WG lead) is(was?) David's legal aid. | ||||||||||||||||||
21 | Dean Jamison | SF/Bay Area | Dean Jamieson | influencer | NA | Mar-17 | Dennis | Briefed (along with Larry Summers) on GVP, interested. | ||||||||||||||||||
22 | DFID | London | missing info | government | direct | missing info | missing info | missing info | ||||||||||||||||||
23 | Donald McNeil Jr. (NY Times) | NYC area | Don McNeil | media | NA | NA | Peter | EHA's contact at the Times. May be useful for press | ||||||||||||||||||
24 | DTRA | Washington DC | Lance Brooks | government | direct | missing info | Peter/Dennis | EHA interfaces with DTRA often through other grants. Dennis knows well. Great candidate for GVP funding | ||||||||||||||||||
25 | England CMO | London | Sally Davies | government | direct | Jun-17 | Dennis/Peter | Dennis and Peter met in July and seemed eager to learn more, recommended several contacts in London. Potential advocate | ||||||||||||||||||
26 | GAVI | Geneva | Seth Berkeley | NGO | in-kind | NA | none yet | Also have a DC office | ||||||||||||||||||
27 | Georgetown | Washington DC | Sam Habibi | academia | NA | Oct-17 | Dennis, Cara | engaged with the ELSI group via Sam Habibi | ||||||||||||||||||
28 | Global Virus Network | Washington DC | Bob Gallo | NGO | NA | missing info | missing info | missing info | ||||||||||||||||||
29 | Gordon and Betty Moore Foundation | SF/Bay Area | Harvey Feinberg | foundation | direct | Aug-17 | Dennis | Have had conversations with Harvey and GVP does not fall within their mandate. However he seems interested and supportive and is a valuable influencer in the field - good to keep on as advisor if possible. Perhaps a potential board member? Also, speaking at PMAC on Plenary 0. | ||||||||||||||||||
30 | Graduate Institute of Geneva | Geneva | Gian Luca Burca | academia | NA | Oct-17 | Dennis, Cara | engaged with the ELSI group via Gian Luca Burca | ||||||||||||||||||
31 | Harvard University | Boston/NE | academia | NA | NA | missing info | missing info | |||||||||||||||||||
32 | Hemsley Charitable Trust | NYC area | Stephanie Cluskley (CEO), Bob Cook | foundation | direct | NA | Dennis | missing info | ||||||||||||||||||
33 | HHS/ASPR | Washington DC | Maria-Julia Marinissen | government | direct | Oct-17 | Cara/Dennis | In contact with MJM | ||||||||||||||||||
34 | Hong Kong University | Hong Kong | Keiji Fukuda | academia | NA | Sep-17 | Peter | Keiji on steering committee. Need to involve the bird flu group on the waterbird work. Not a funder. | ||||||||||||||||||
35 | ICONIQ | SF/Bay Area | NA | VC | direct | NA | none yet | venture funding arm of Mark Zuckerberg and others. Not yet contacted, but discussed in relation to the Chan-Zuckerberg Initiative | ||||||||||||||||||
36 | Illumina | SF/Bay Area | Christiane Honisch | industry (pharma/tech) | direct and in-kind | Mar-17 | Nathan/Eddy | Very keen to get involved. Not clear that they're committed to funding (even in-kind support), but very interested in our data. | ||||||||||||||||||
37 | Institute Pasteur | Paris | Christine Gillier | NGO | ||||||||||||||||||||||
38 | Japan - JICA/MOFA | Japan | missing info | government | direct | missing info | missing info | Eri can facilitate communication in Japanese | ||||||||||||||||||
39 | Johnson & Johnson | NYC area | Alan Tennenberg | industry (pharma/tech) | direct and in-kind | Jul-17 | Peter | Dennis, Peter and Brooke have call scheduled for 12/06. Interested but uncommitted. Alan is the GHSA rep for J&J. | ||||||||||||||||||
40 | Korea - KOICA | Korea | missing info | government | direct | Jul-17 | Peter | Peter gave a talk in July, no direct funding conversations. | ||||||||||||||||||
41 | Lancet | London | Richard Horton | media | NA | Jul-17 | Ron/Dennis | Non-funder. Offered to publish editorial in time with PMAC launch, but need at least ~6 months for review process. | ||||||||||||||||||
42 | Laurie Garrett | NYC area | Laurie Garrett | influencer | NA | NA | Dennis | science writer, has written extensively on pandemics / pandemic preparedness. | ||||||||||||||||||
43 | London School | London | academia | NA | Jul-17 | Dennis | Dennis gave talk in July - likely not funders but David Heymann is influential and good to have on our side. | |||||||||||||||||||
44 | Merck | NYC area | Amy Espeseth | industry (pharma/tech) | direct and in-kind | Aug-16 | Cara/Dennis | Was not able to attend Beijing. Involved at Bellagio. Little recent followup, no financial commitments. | ||||||||||||||||||
45 | Merieux Foundation | Paris | Guy | industry (pharma/tech) | direct and in-kind | Aug-17 | Jonna | Interested, but don't seem ready to become a funding partner. | ||||||||||||||||||
46 | Michael McCullough (entrepreneur, investor) | SF/Bay Area | Michael McCullough | influencer | NA | Sep-16 | Nathan | Was or is on the board of Metabiota. No apparent recent contact | ||||||||||||||||||
47 | Microsoft Research | Seattle | Lucas Joppa, Ethan Jackson, Jonathan Carlson | industry (pharma/tech) | direct and in-kind | Jun-17 | Peter | Peter and Brooke met over the phone in June. Interesting group but focused in the US and on vector technology not useful to us. Potentially should continue conversations around data platform / data hosting. | ||||||||||||||||||
48 | NAMRU | Washington DC | Fanca Jones | government | direct | missing info | Dennis | Naval Medical Research Unit. Dennis gave talk? | ||||||||||||||||||
49 | NIH/NIAID/Fogerty | Washington DC | Tony Fauci, Roger Glass, Mike Kurilla | government | direct | Oct-17 | Peter/Dennis | Mike Kurilla an advocate and on the steering committee. | ||||||||||||||||||
50 | No More Epidemics | Boston/NE | Jonathan Quick | NGO | NA | NA | missing info | missing info | ||||||||||||||||||
51 | Noweigian MOH | Oslo | NA | government | direct | NA | Peter, Dennis | Contacts via Richard Hatchett/CEPI, which is housed in/adjacent to the Norwegian Department of Public Health. | ||||||||||||||||||
52 | NSC | Washington DC | Tim Ziemer | government | direct | Jul-17 | Dennis/Cara | Tim Ziemer very interested. | ||||||||||||||||||
53 | OIE | Paris | Monique Eloit(CEO)/Billy Karesh | multilateral | direct and in-kind | Oct-17 | Peter/Dennis | Billy on an advisory board. Keen to take on much of the waterbird work. Dennis and Eddy met with a group in Ottowa recently. | ||||||||||||||||||
54 | OSTP | Washington DC | Jean-Paul Chretien | government | NA | Dec-17 | Dennis/Cara | Spoke to a large mixed group - seemed supportive but pre-Trump administration. | ||||||||||||||||||
55 | Paul Allen/Vulcan | Seattle | Richard Reagan | foundation | direct | Sep-17 | Dennis/Cara | Org going through a lot of turmoil. Have been pitched twice, possibly to wrong people (i.e. not Paul). Tabled until there is some consistency. | ||||||||||||||||||
56 | Peggy Hamburg | Washington DC | Kate Bond | government | NA | missing info | Former FDA administrator, perhaps less relevant now. | |||||||||||||||||||
57 | Rockefeller | NYC area | Michael Meyers | foundation | direct | Apr-17 | Dennis/Peter | Peter involved with Rockefeller via the Planetary Health Alliance. Knows of GVP. Alternate contact: Cori Bargmann, suggested by Christine Tato at BioHub. | ||||||||||||||||||
58 | Science Philanthropy Alliance | SF/Bay Area | Marc Kastner, Valerie Kohn | foundation | direct | Jan-17 | Jonna/Nathan | Met in Jan 2017. Pitch was still too broad (asking for ~3 bil, when the SPA is made up of smaller donors. Need a revamped pitch with $300,000-$500,000 sized asks. | ||||||||||||||||||
59 | Skoll Global Threats | SF/Bay Area | Larry Brillian/Mark Smolinski | foundation | direct | Sep-17 | Jonna | Jonna working on convincing him to commit to funding GVP in one country, likely Thailand. Interested but has not yet committed. | ||||||||||||||||||
60 | UCSF | SF/Bay Area | Richard Feachem | academia | NA | Sep-17 | Dennis | Richard is very supportive but not a funder. Potentially could play a board role. | ||||||||||||||||||
61 | UNESCO | Paris | Dr Casimiro Vizzini | multilateral | NA | missing info | missing info | missing info | ||||||||||||||||||
62 | University of Washington | Seattle | Marguerite Pappaioanou | academia | direct | NA | missing info | Strongly linked to Gates. No recent outreach that I know of. | ||||||||||||||||||
63 | US Embassy in China | Beijing | Miles Toder | government | direct and in-kind | Oct-17 | Dennis, Peter, Eddy | Most recent engagement via Eddy at Beijing Genome Conference. Eager, interested, working to get GVP on the Trump-Xi meeting agenda. | ||||||||||||||||||
64 | Wellcome Trust | London | Jerermy Farrar + Mike Turner and Philip Price | NGO | direct | Jul-17 | Dennis/Cara | Not the right contact at Wellcome. Need to get to Jeremy. Likely needs a British lead for this to work - Wellcome rarely donates to American NGOs. Much of the funding is controlled in-country. | ||||||||||||||||||
65 | Wellcome-Sanger | London | Mike Stratton | NGO + industry (pharma/tech) | in-kind | Jul-17 | Eddy | Interested but focused as an organization more on human + bacterial sequencing. Mike a good friend of Eddy's. Trying to figure out how they could get involved - Eddy suggested in-kind sequencing. | ||||||||||||||||||
66 | WHO | Geneva | Maria van Kerkhove, Steve Solomon | multilateral | NA | Aug-17 | Dennis | Maria & Steve on steering committee. Need buy-in, but agree that this shouldn't be housed in the WHO. | ||||||||||||||||||
67 | Thailand / Mahidol University | Thailand | Prasert Auewarakul | academia | in-kind | Jun-17 | Jonna | Prasert has obtained a government grant and is seeking to use it toward GVP-style activities. MOUs in draft process, may be shared with Thailand team | ||||||||||||||||||
68 | GISAID | SF/Bay Area | Peter Bogner | NGO | in-kind | Aug-17 | Dennis | head of the GISAID platform for sharing bird flu samples. Provided guidance on the data platform for GVP. Not a funder, but could potentially provide expertise/hosting for data. | ||||||||||||||||||
69 | Yale University | Boston/NE | David Stanton | academia | NA | NA | Cara/Dennis | Eri also has connection | ||||||||||||||||||
70 | ||||||||||||||||||||||||||
71 | ||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||
73 | ||||||||||||||||||||||||||
74 | ||||||||||||||||||||||||||
75 | ||||||||||||||||||||||||||
76 | ||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||
78 | ||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||
80 | ||||||||||||||||||||||||||
81 | ||||||||||||||||||||||||||
82 | ||||||||||||||||||||||||||
83 | ||||||||||||||||||||||||||
84 | ||||||||||||||||||||||||||
85 | ||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||
87 | ||||||||||||||||||||||||||
88 | ||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||
90 | ||||||||||||||||||||||||||
91 | ||||||||||||||||||||||||||
92 | ||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||
94 | ||||||||||||||||||||||||||
95 | ||||||||||||||||||||||||||
96 | ||||||||||||||||||||||||||
97 | ||||||||||||||||||||||||||
98 | ||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||
100 |